The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38
Open accessAbstract
Metabolic syndrome is a growing health problem worldwide. It is therefore imperative to develop new strategies to treat this pathology. In the past years, the manipulation of NAD+ metabolism has emerged as a plausible strategy to ameliorate metabolic syndrome. In particular, an increase in cellular NAD+ levels has beneficial effects, likely because of the activation of sirtuins. Previously, we reported that CD38 is the primary NAD+ase in mammals. Moreover, CD38 knockout mice have higher NAD+ levels and are protected against obesity and metabolic syndrome. Here, we show that CD38 regulates global protein acetylation through changes in NAD+ levels and sirtuin activity. In addition, we characterize two CD38 inhibitors: quercetin and apigenin. We show that pharmacological inhibition of CD38 results in higher intracellular NAD+ levels and that treatment of cell cultures with apigenin decreases global acetylation as well as the acetylation of p53 and RelA-p65. Finally, apigenin administration to obese mice increases NAD+ levels, decreases global protein acetylation, and improves several aspects of glucose and lipid homeostasis. Our results show that CD38 is a novel pharmacological target to treat metabolic diseases via NAD+-dependent pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, apigenin, a naturally occurring flavonoid, enhances NAD+ levels in human cells and mouse liver tissue, and improves glucose and lipid homeostasis in mouse models of obesity226.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [226]
In the citing paper
“For example, apigenin, a naturally occurring flavonoid, enhances NAD+ levels in human cells and mouse liver tissue, and improves glucose and lipid homeostasis in mouse models of obesity226.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [226]
In the citing paper
“have been implicated in the regulation of chromosomal integrity, DNA damage repair, metabolism, aging, health span, and longevity”
From A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline (2018) · cites this paper as Escande et al., 2013
In the citing paper
“Sirtuins are enzymes that remove specific covalent modification in lysine residues, such as acetylation, malonylation, and succinylation, in several proteins”
From A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline (2018) · cites this paper as Escande et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,317
Eckel, R. H., Grundy, S. M., & Zimmet, P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,755
Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.
Hedley, A. A., Ogden, C., Johnson, C. L., Carroll, M., Curtin, L. R., & Flegal, K. (2004) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.291.23.2847 · Cited by 4,670
Global nutrition transition and the pandemic of obesity in developing countries
Popkin, B. M., Adair, L. S., & Ng, S. W. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00456.x · Cited by 4,313
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Self-citationSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Self-citationTranscriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,690
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648
NAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481
Camacho-Pereira, J., Tarragó, M. G., Chini, C. C. S., Nin, V., Escande, C., Warner, G. M., Puranik, A. S., Schoon, R. A., Reid, J. M., Galina, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.006 · Cited by 901
Self-citationTherapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865
Self-citationSlowing ageing by design: the rise of NAD+ and sirtuin-activating compounds
Bonkowski, M. S., & Sinclair, D. A. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.93 · Cited by 834
Self-citationHow the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Icard, P., Shulman, S. D., Farhat, D., Steyaert, J., Alifano, M., & Lincet, H. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.001 · Cited by 664
NAD+ homeostasis in health and disease
Katsyuba, E., Romani, M., Hofer, D., & Auwerx, J. (2020) · Nature Metabolism · doi:10.1038/s42255-019-0161-5 · Cited by 627
Interventions to slow aging in humans: are we ready?
Longo, V. D., Antebi, A., Bartke, A., Barzilai, N., Brown‐Borg, H. M., Caruso, C., Curiel, T. J., Cabo, R., Franceschi, C., Gems, D., et al. (2015) · Aging Cell · doi:10.1111/acel.12338 · Cited by 592
“Data from studies conducted in mouse models of obesity and aging have demonstrated that increasing NAD levels protects mice from metabolic decline and aging (Yoshino et al., 2011; Canto et al., 2012; Escande et al., 2012) and reverses mitochondrial decline, inflammation, and markers of muscle wasting (Gomes et al.”
Self-citationNAD(+) in aging: molecular mechanisms and translational implications
Fang, E. F., Lautrup, S., Hou, Y., Demarest, T. G., Croteau, D. L., Mattson, M. P., & Bohr, V. A. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.08.001 · Cited by 501
Sirtuins and NAD + in the Development and Treatment of Metabolic and Cardiovascular Diseases
Kane, A. E., & Sinclair, D. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.312498 · Cited by 497
Self-citationSirtuins, a promising target in slowing down the ageing process
Grabowska, W., Sikora, E., & Bielak-Zmijewska, A. (2017) · Biogerontology · doi:10.1007/s10522-017-9685-9 · Cited by 470
It takes two to tango: NAD(+) and sirtuins in aging/longevity control
Imai, S.-I., & Guarente, L. (2016) · npj Aging and Mechanisms of Disease · doi:10.1038/npjamd.2016.17 · Cited by 394
Tarragó, M. G., Chini, C. C. S., Kanamori, K. S., Warner, G. M., Caride, A., de Oliveira, G. C., Rud, M., Samani, A., Hein, K. Z., Huang, R., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.016 · Cited by 384
Self-citationQuercetin and metabolic syndrome: A review
Hosseini, A., Razavi, B. M., Banach, M., & Hosseinzadeh, H. (2021) · Phytotherapy Research · doi:10.1002/ptr.7144 · Cited by 390
Role of NAD+ in regulating cellular and metabolic signaling pathways
Amjad, S., Nisar, S., Bhat, A. A., Shah, A. R., Frenneaux, M. P., Fakhro, K. A., Haris, M., Reddy, R. D., Patay, Z. J., Baur, J. A., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101195 · Cited by 413
The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases
Hogan, K. A., Chini, C. C. S., & Chini, E. N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01187 · Cited by 348
Self-citationRepairing mitochondrial dysfunction in disease
Sorrentino, V., Menzies, K. J., & Auwerx, J. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104908 · Cited by 337
CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity
Piedra-Quintero, Z. L., Wilson, Z., Nava, P., & Guerau‐de‐Arellano, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.597959 · Cited by 351
Protein acetylation in metabolism – metabolites and cofactors
Menzies, K. J., Zhang, H., Katsyuba, E., & Auwerx, J. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.181 · Cited by 331
Dong, J., Zhang, X., Zhang, L., Bian, H., Xu, N., Bao, B., & Liu, J. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m038786 · Cited by 299
Castro-Portuguez, R., & Sutphin, G. L. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110841 · Cited by 296
Pharmacokinetic properties and drug interactions of apigenin, a natural flavone
Tang, D., Chen, K., Huang, L., & Li, J. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1251903 · Cited by 249
Mitochondria: Their relevance during oocyte ageing
van der Reest, J., Cecchino, G. N., Haigis, M. C., & Kordowitzki, P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101378 · Cited by 258
NAD+ homeostasis in human health and disease
Perez, R. Z., Wanders, R. J. A., van Karnebeek, C., & Houtkooper, R. H. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202113943 · Cited by 244
The importance of NAMPT / NAD / SIRT1 in the systemic regulation of metabolism and ageing
Imai, S., & Yoshino, J. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12171 · Cited by 240
The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging
Chini, E. N., Chini, C. C. S., Espindola Netto, J. M., de Oliveira, G. C., & van Schooten, W. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.001 · Cited by 227
Self-citationModulating NAD+ metabolism, from bench to bedside
Katsyuba, E., & Auwerx, J. H. (2017) · The EMBO Journal · doi:10.15252/embj.201797135 · Cited by 231
Nicotinamide Riboside—The Current State of Research and Therapeutic Uses
Mehmel, M., Jovanović, N. D., & Spitz, U. P. (2020) · Nutrients · doi:10.3390/nu12061616 · Cited by 231
NAD and the aging process: role in life, death and everything in between
Chini, C. C. S., Tarragó, M. G., & Chini, E. N. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.003 · Cited by 208
Self-citationAslibekyan, S. W., Demerath, E. W., Mendelson, M., Zhi, D., Guan, W., Liang, L., Sha, J., Pankow, J. S., Liu, C., Irvin, M. R., et al. (2015) · Obesity · doi:10.1002/oby.21111 · Cited by 214
CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions
Amici, S. A., Young, N. A., Miranda, J. N., Jablonski, K., Arcos, J., Rosas, L. E., Papenfuss, T. L., Torrelles, J. B., Jarjour, W. N., & Guerau‐de‐Arellano, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01593 · Cited by 203
The Plasma NAD + Metabolome Is Dysregulated in “Normal” Aging
Clement, J., Wong, M. W. K., Poljak, A., Sachdev, P. S., & Braidy, N. (2018) · Rejuvenation Research · doi:10.1089/rej.2018.2077 · Cited by 206
Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
Stojanović, S. D., Fiedler, J., Bauersachs, J., Thum, T., & Sedding, D. G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz919 · Cited by 188
Kashyap, P., Shikha, D., Thakur, M., & Aneja, A. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13950 · Cited by 182
NAD+ biosynthesis, aging, and disease
Johnson, S., & Imai, S. (2018) · F1000Research · doi:10.12688/f1000research.12120.1 · Cited by 178
Feng, X., Weng, D., Zhou, F., Owen, Y. D., Qin, H., Zhao, J., Wenyu, Huang, Y., Chen, J., Fu, H., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.017 · Cited by 186
Hong, W., Mo, F., Zhang, Z., Huang, M., & Wei, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00246 · Cited by 182
Sirtuins and their Biological Relevance in Aging and Age-Related Diseases
Zhao, L., Cao, J., Hu, K., He, X., Dou, Y., Tong, T., & Han, L. (2020) · Aging and Disease · doi:10.14336/ad.2019.0820 · Cited by 178
Jung, U. J., Cho, Y.-Y., & Choi, M. (2016) · Nutrients · doi:10.3390/nu8050305 · Cited by 160
The role of NAD+ metabolism and its modulation of mitochondria in aging and disease
Yusri, K., Jose, S., Vermeulen, K. S., Tan, T. C. M., & Sorrentino, V. (2025) · npj Metabolic Health and Disease · doi:10.1038/s44324-025-00067-0 · Cited by 194
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy
Estrela, J. M., Mena, S., Obrador, E., Benlloch, M., Castellano, G., Palmer, R. S., & Dellinger, R. W. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01026 · Cited by 144
Kong, M., Xie, K., Lv, M., Li, J., Yao, J., Yan, K., Wu, X., Xu, Y., & Ye, D. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110975 · Cited by 153
Apigenin: A current review on its beneficial biological activities
Zhou, X., Wang, F., Zhou, R., Song, X., & Xie, M.-L. (2017) · Journal of Food Biochemistry · doi:10.1111/jfbc.12376 · Cited by 139
Peng, J., Li, Q., Li, K., Zhu, L., Lin, X., Lin, X., Shen, Q., Li, G., & Xie, X. S. (2017) · Journal of Diabetes Research · doi:10.1155/2017/3417306 · Cited by 141
RetractedRoles of CD38 in the Immune Response to Infection
Glaría, E., & Valledor, A. F. (2020) · Cells · doi:10.3390/cells9010228 · Cited by 139
NAD metabolism: Role in senescence regulation and aging
Chini, C. C. S., Cordeiro, H. S., Tran, N. L. K., & Chini, E. N. (2023) · Aging Cell · doi:10.1111/acel.13920 · Cited by 148
Self-citationCambronne, X. A., & Kraus, W. L. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.05.010 · Cited by 137
Why NAD + Declines during Aging: It’s Destroyed
Schultz, M. B., & Sinclair, D. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.022 · Cited by 126
Self-citationKirkland, J. B., & Meyer‐Ficca, M. L. (2018) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2017.11.003 · Cited by 141
Chu, J., Shi, P., Yan, W., Fu, J., Yang, Z., He, C., Deng, X., & Liu, H. (2018) · Nanoscale · doi:10.1039/c8nr02538j · Cited by 131
Braidy, N., Poljak, A., Grant, R., Jayasena, T., Mansour, H., Chan‐Ling, T., Guillemin, G. J., Smythe, G. A., & Sachdev, P. S. (2013) · Biogerontology · doi:10.1007/s10522-013-9489-5 · Cited by 123
RetractedOgura, Y., Kitada, M., Xu, J., Monno, I., & Koya, D. (2020) · Aging · doi:10.18632/aging.103410 · Cited by 118
Key Signaling Pathways in Aging and Potential Interventions for Healthy Aging
Yu, M., Zhang, H., Wang, B. Z., Zhang, Y., Zheng, X., Shao, B., Zhuge, Q., & Jin, K. (2021) · Cells · doi:10.3390/cells10030660 · Cited by 117
Potential Modulation of Sirtuins by Oxidative Stress
Santos, L., Escande, C., & Denicola, A. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9831825 · Cited by 120
Self-citationTherapeutic application of natural products: NAD+ metabolism as potential target
Guo, C., Huang, Q., Wang, Y., Yao, Y., Li, J., Chen, J., Wu, M., Zhang, Z., Mingyao, E., Qi, H., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154768 · Cited by 117
Interplay between compartmentalized NAD + synthesis and consumption: a focus on the PARP familyPreprint
Cohen, M. S. (2020) · Genes & Development · doi:10.1101/gad.335109.119 · Cited by 111
Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways
Lv, Y., Gao, X., Luo, Y., Fan, W., Shen, T., Ding, C., Yao, M., Song, S., & Yan, L. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.05.015 · Cited by 108
Dietary plant flavonoids in prevention of obesity and diabetes
Dinda, B., Dinda, M., Roy, A., & Dinda, S. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.08.006 · Cited by 107
Croitoru, A.-M., Karaçelebi, Y., Saatcioglu, E., Altan, E., Ulağ, S., Aydoğan, H. K., Şahin, A., Motelică, L., Oprea, O., Tihăuan, B.-M., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070957 · Cited by 104
Differential effects of dietary flavonoids on adipogenesis
Khalilpourfarshbafi, M., Gholami, K., Murugan, D. D., Sattar, M. Z. A., & Abdullah, N. A. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1663-8 · Cited by 111
Seo, S., Lee, M.-S., Chang, E., Shin, Y., Oh, S., Kim, I.-H., & Kim, Y. (2015) · Nutrients · doi:10.3390/nu7095385 · Cited by 100
“Indeed, rutin supplemented diet significantly increases plasma quercetin concentration [54–56], which is involved in the activation of SIRT1, a NAD-dependent deacetlyase [57].”
BackgroundShu, B., Ye, F., Gui, Y., Lu, Q., Wei, W., Xue, X., Sun, X., He, W., Yang, J., & Dai, C. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.10.014 · Cited by 100
Gao, L., Zhang, Z., Lü, J., & Pei, G. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00316 · Cited by 98
Yoshino, J., & Imai, S. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-637-5_14 · Cited by 95
Wang, C., & Wei, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155266 · Cited by 97
Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule
Elhassan, Y., Philp, A., & Lavery, G. G. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00092 · Cited by 93
Kratz, E. M., Sołkiewicz, K., Kubis-Kubiak, A., & Piwowar, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020630 · Cited by 97
Roboon, J., Hattori, T., Ishii, H., Takarada‐Iemata, M., Nguyen, D. T., Heer, C. D., O’Meally, D., Brenner, C., Yamamoto, Y., Okamoto, H., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15367 · Cited by 94
Apigenin prevents metabolic syndrome in high-fructose diet-fed mice by Keap1-Nrf2 pathway
Yang, M. H., Jiang, Z., Li, C.-G., Zhu, Y., Li, Z., Tang, Y., & Ni, C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.108 · Cited by 88
The CD38 glycohydrolase and the NAD sink: implications for pathological conditions
Zeidler, J. D., Hogan, K. A., Agorrody, G., Peclat, T., Kashyap, S., Kanamori, K. S., Gomez, L. S., Mazdeh, D. Z., Warner, G. M., Thompson, K. L., et al. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00451.2021 · Cited by 95
Self-citationNAMPT as a Therapeutic Target against Stroke
Wang, P., & Miao, C. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.08.012 · Cited by 87
Therapeutic potential of boosting NAD+ in aging and age-related diseases
Aman, Y., Qiu, Y., Tao, J., & Fang, E. F. (2018) · Translational Medicine of Aging · doi:10.1016/j.tma.2018.08.003 · Cited by 92
Choi, W. H., Son, H. J., Jang, Y. J., Ahn, J., Jung, C. H., & Ha, T. Y. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700218 · Cited by 81
Bock, K. W. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114093 · Cited by 84
Tannous, C., Booz, G. W., Altara, R., Muhieddine, D. H., Mericskay, M., Refaat, M. M., & Zouein, F. A. (2020) · Acta Physiologica · doi:10.1111/apha.13551 · Cited by 80
Abid, R., Ghazanfar, S., Farid, A., Sulaman, S. M., Idrees, M., Amen, R. A., Muzammal, M., Shahzad, M. K., Mohamed, M. O., Khaled, A. A., et al. (2022) · Molecules · doi:10.3390/molecules27134304 · Cited by 86
Antiaging effects of bioactive molecules isolated from plants and fungi
Martel, J., Ojcius, D. M., Ko, Y., Chang, C., & Young, J. D. (2019) · Medicinal Research Reviews · doi:10.1002/med.21559 · Cited by 79
Luo, X., Li, R., & Yan, L. (2015) · Journal of Diabetes Research · doi:10.1155/2015/512618 · Cited by 81
Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration
Pehar, M., Harlan, B. A., Killoy, K. M., & Vargas, M. R. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7145 · Cited by 77
Zhang, Z.-F., Fan, S., Zheng, Y., Lu, J. L., Wu, D., Shan, Q., & Hu, B. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.002 · Cited by 75
Procyanidins and Alzheimer’s Disease
Zhao, S., Zhang, L., Yang, C., Li, Z., & Rong, S. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1469-6 · Cited by 75
Castillo, E. C., Morales, J. A., Chapoy‐Villanueva, H., Silva‐Platas, C., Treviño‐Saldaña, N., Guerrero-Beltrán, C. E., Bernal‐Ramírez, J., Torres‐Quintanilla, A., GarcÃa, N., Youker, K. A., et al. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000151 · Cited by 74
At the interface of antioxidant signalling and cellular function: Key polyphenol effects
Kerimi, A., & Williamson, G. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500940 · Cited by 74
Ruggieri, S., Orsomando, G., Sorci, L., & Raffaelli, N. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.02.021 · Cited by 71
Keeping the balance in NAD metabolism
Strømland, Ø., Niere, M., Nikiforov, A. A., VanLinden, M. R., Heiland, I., & Ziegler, M. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180417 · Cited by 73
Gentile, D., Fornai, M., Colucci, R., Pellegrini, C., Tirotta, E., Benvenuti, L., Segnani, C., Ippolito, C., Duranti, E., Virdis, A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195502 · Cited by 71
Cortés‐Rojo, C., Vargas-Vargas, M. A., Olmos‐Orizaba, B. E., Rodríguez-Orozco, A. R., & Calderón‐Cortés, E. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165801 · Cited by 73
Bock, K. W. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114220 · Cited by 73
Luteolinidin Protects the Postischemic Heart through CD38 Inhibition with Preservation of NAD(P)(H)
Boslett, J., Hemann, C., Zhao, Y. J., Lee, H.-C., & Zweier, J. L. (2017) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.239459 · Cited by 69
Zhang, Z.-F., Zhang, Y., Fan, S., Zhuang, J., Zheng, Y., Lu, J. L., Wu, D., Shan, Q., & Hu, B. (2014) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2014.09.012 · Cited by 68
Hong, Y., Liu, M., Wang, L., Zu, Y., Wu, C., Li, C., Zhang, R., Lu, H., Li, F., Xi, S., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00651-9 · Cited by 70
Kerimi, A., & Williamson, G. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7086 · Cited by 70
Nutraceutical Activation of Sirt1: A Review
DiNicolantonio, J. J., McCarty, M. F., & O'Keefe, J. H. (2022) · Open Heart · doi:10.1136/openhrt-2022-002171 · Cited by 65
Audrito, V., Managò, A., Gaudino, F., Sorci, L., Messana, V. G., Raffaelli, N., & Deaglio, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01720 · Cited by 67
Cellular Compartmentation and the Redox/Nonredox Functions of NAD +
Kulkarni, C. A., & Brookes, P. S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7722 · Cited by 68
Zhang, J., Zhao, L., Cheng, Q., Ji, B., Yang, M., Sanidad, K. Z., Wang, C., & Zhou, F. L. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b03574 · Cited by 63
Hedayati, N., Naeini, M. B., Mohammadinejad, A., & Mohajeri, S. A. (2019) · Phytotherapy Research · doi:10.1002/ptr.6492 · Cited by 63
Yang, J., Peng, S., Zhang, B., Houten, S. M., Schadt, E. E., Zhu, J., Suh, Y., & Tu, Z. (2019) · GeroScience · doi:10.1007/s11357-019-00106-x · Cited by 64
The balance between NAD+ biosynthesis and consumption in ageing
Strømland, Ø., Diab, J., Ferrario, E., Sverkeli, L. J., & Ziegler, M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111569 · Cited by 64
Metadata
- Authors
- Escande, C., Nin, V., Price, N. L., Capellini, V., Gomes, A. P., Barbosa, M. T., O’Neil, L., White, T. A., Sinclair, D. A., & Chini, E. N.
- Affiliations
- Mayo Clinic (US)
- Department of Anesthesiology and Kogod Aging Center Mayo Clinic, Rochester, Minnesota
- Harvard University (US)
- Corresponding author
- Chini, Eduardo N.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2013-03-14
- Volume
- 62
- Issue
- 4
- Pages
- 1084-1093
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3609577
- OpenAlex
- W2112866277
- Cited by
- 332
- References
- 48
- Citations by year
- 2026: 27 · 2025: 20 · 2024: 30 · 2023: 17 · 2022: 37 · 2021: 38 · 2020: 33 · 2019: 23 · 2018: 31 · 2017: 25 · 2016: 17 · 2015: 18 · 2014: 11 · 2013: 5
- FWCI
- 5.35
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-04-01)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institute on Aging (R37AG028730, T32AG000222)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK050456, R01DK084055)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- apigenin, CD38, NAD+ metabolism, sirtuins, protein acetylation, quercetin, metabolic syndrome, obesity, p53 acetylation, glucose homeostasis, lipid homeostasis, flavonoids, CD38 inhibitors
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Mice, Inbred C57BL, NAD, Obesity, Quercetin, Random Allocation, Molecular Structure, Mice, Knockout, Metabolic Syndrome, Cell Line, Tumor, Apigenin, Mice, ADP-ribosyl Cyclase 1, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review